Gujarat Kidney & Super Speciality, a regional healthcare company, has filed its draft red herring prospectus (DRHP) with the stock market regulator Securities and Exchange Board of India (SEBI) for an IPO.
Gujarat Kidney & Super Speciality IPO is an entirely fresh issue of 2.2 crore equity shares. As it has only a fresh issue, all the IPO proceeds will be used for the company’s purposes.
The company aims to use the IPO for acquiring businesses, buying equipment, and covering its working capital needs.
Gujarat Kidney & Super Speciality IPO Funds Deployment
The company plans to use ₹77 crore from the IPO proceeds to acquire Parekhs Hospital in Ahmedabad. Moreover, ₹12.4 crores will be utilized for partial payment of Ashwini Medical Centre, which has already been bought from them.
Further, ₹30.2 crore shall go for capital expenditure requirements and ₹7.3 crore for purchasing robotics equipment for the new hospital in Vadodara.
The ₹1.5 crore would be used for certain borrowings repayments that have been taken by the company.
Lastly, the rest of the funds would be allocated for the inorganic growth and general purposes.
For Qualified Institutional Buyers, 75% allocation and not more than 15% for NII. Further 10% for retail individuals respectively.
About Gujarat Kidney & Super Speciality Company.
Gujarat Kidney & Super Speciality was founded in 2014 and is known as a regional healthcare company located in Gujarat.
It runs a group of medium-sized hospitals that offer a range of healthcare services, mainly focusing on specialized and advanced treatments.
Gujarat Kidney & Super Speciality’s Strategies
- Attract growth through partnerships and acquisitions.
- Always make efforts to enhance current operations.
- Carrying out actions to enhance the efficiency of current operations.
- Continue to recruit and retain skilled healthcare professionals
- Strengthen our existing hospitals and their offerings and add new capabilities and specialties.
Details of Promoters and Managing Directors
The company is led by a promoter and a managing director. Dr Pragnesh Yashwantsingh Bharpoda is the company’s promoter and managing director.
They are skilled and have years of experience in the medical industry, enhancing the company’s growth. Moreover, they have also made a name in the field of urology.
Gujarat Kidney & Super Speciality’s Financial Statement
Gujarat Kidney and Super Speciality Limited’s revenue increased in 2024 ₹41.04 crore, while it was ₹34.01 crore in 2023. Moreover, profit after tax also grew from ₹2.80 crore in 2023 to ₹4.34 crore in 2024.
Gujarat Kidney & Super Speciality IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | To be Updated Soon |
Gujarat Kidney & Super Speciality Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax |
| 2022 | ₹0.79 | ₹0.65 | ₹0.10 |
| 2023 | ₹0.00 | ₹0.01 | ₹0.01 |
| 2024 | ₹5.48 | ₹3.21 | ₹1.71 |
| September 2024 | ₹18.72 | ₹11.16 | ₹5.63 |
Gujarat Kidney & Super Speciality IPO Valuation – FY2024
Gujarat Kidney & Super Speciality IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹0.49 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 15.86% |
| Net Asset Value (NAV): | ₹3.09 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Yatharth Hospital & Trauma Care Services Limited | 14.46 | 28.64 | 13.09 | 101.84 | 670.55 Cr. |
| GPT Healthcare Limited | 5.96 | 23.66 | 21.86 | 26.63 | 400.19 Cr. |
| KMC Speciality Hospitals (India) Ltd | 1.86 | 34.19 | 24 | 8.80 | 177.18 Cr. |
Objects of the Issue
- Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad
- Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre”
- Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for women’s health care in Vadodara;
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company and
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.
IPO Lead Managers aka Merchant Bankers
- Nirbhay Capital Services Private Limited
